A study for the efficacy of BSL-0051 and BSL-0052 on healthy ski
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000024603
- Lead Sponsor
- Kao Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 10
Not provided
1.Panelists with illnesses or diseases which in the opinion of the investigators, might interfere with the conduct of the study or the interpretation of results. Panelists especially with any skin irritation, skin condition (such as rosacea, eczema, atopic dermatitis, or psoriasis), or severe acne on their faces. 2.Panelists who take any supplements, OTC or prescription medications, especially anti-inflammation agents, anti-bacterial agents, analgesic agents, hormonal agents, laxative agents, intestinal agents, etc. 3.Panelists under the care of a doctor taking prescription medication (topical) for any facial skin issues. 4.Panelists with allergy or sensitivity to any facial care product, facial moisturizer, facial cleanser, pore strip, or to any specific ingredient or fragrance used in these types of products. 5.Panelists who refrain from sun exposure, tanning beds, sunless tanners, and skin lightening products until the study completes. 6.Panelists currently participating in, or scheduled to participate in, another facial study during the study period. 7.Panelists having any conditions which in the opinion of the investigators, might interfere with the conduct of the study or the interpretation of results.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of the sebum content, the sebum composition, the gene expressions, the skin moisture content, the transepidermal water loss and the skin color and the dermatological assessment before and after the application of BSL-0051 and BSL-0052 for 4 weeks.
- Secondary Outcome Measures
Name Time Method